BRIEF published on 05/06/2025 at 07:35, 1 year 5 months ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
BRIEF published on 04/25/2025 at 07:35, 1 year 6 months ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
BRIEF published on 04/25/2025 at 07:35, 1 year 6 months ago Présentation de Sensorion sur la thérapie génique lors de la réunion annuelle de l'ASPO 2025 Essai Clinique Thérapie Génique Perte Auditive SENS-501 Oto-rhino-laryngologie Pédiatrique
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Sensorion annonce la participation du Dr. Natalie Loundon à la réunion annuelle de la Société américaine d'oto-rhino-laryngologie pédiatrique pour présenter la thérapie génique SENS-501 pour la perte auditive Thérapie Génique Sensorion Perte Auditive Dr. Natalie Loundon ASPO
BRIEF published on 04/18/2025 at 09:29, 1 year 6 months ago Sensorion prépare son Assemblée générale du 12 mai 2025 Actionnaires Biotechnologie Assemblée Générale Sensorion Perte Auditive
BRIEF published on 04/18/2025 at 09:29, 1 year 6 months ago Sensorion prepares its General Meeting of May 12, 2025 Shareholders Biotechnology General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 04/18/2025 at 09:24, 1 year 6 months ago Informations privilégiées / Autres communiqués Sensorion annonce la mise à disposition des documents préparatoires pour son Assemblée générale mixte du 12 mai 2025. Consultation possible sur www.sensorion.com Biotechnologie Documents Préparatoires Assemblée Générale Mixte Sensorion Perte Auditive
Published on 10/30/2026 at 23:35, 2 days 10 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 11 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 15 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 19 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/02/2026 at 09:30, 1 hour 2 minutes ago Europe's first bond for New Space investing is open for subscription from today: European Space Bond, 8% p.a. fixed interest.
Published on 11/02/2026 at 09:20, 1 hour 12 minutes ago Original-Research: SFC Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/02/2026 at 09:00, 1 hour 32 minutes ago Original-Research: Gallmetzer HealthCare SpA (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 1 hour 32 minutes ago Original-Research: bet-at-home.com AG (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 1 hour 32 minutes ago Mutares has sold SRT Group and its subsidiaries to Quiver
Published on 11/02/2026 at 08:40, 1 hour 51 minutes ago Octobre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/30/2026 at 23:00, 2 days 11 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 11 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
